$982.29
Regeneron Pharmaceuticals is a biotech company headquartered in New York. While it works on a number of drugs and diseases, it's most recently been in the news for REGN-COV2 — the experimental antibody cocktail.
The antibody cocktail is being studied as a possible treatment for the novel coronavirus.
How to buy shares in Regeneron Pharmaceuticals
- Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
- Fund your account. Add money to your account via bank transfer, debit card or credit card.
- Search the platform by ticker symbol. REGN in this case.
- Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
- Submit the order. It's that simple.
Our top broker picks for buying Regeneron Pharmaceuticals stock
- No-cost financial planning and automated investing
- $0 commission on stocks, ETFs and options
- Get up to $1,000 in stock when you fund a new account within 30 days
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Get $100-$5,000 when you open an account with $5,000 to $1,000,000+
- Earn 5% interest on uninvested cash
- Get up to $50,000 in instant deposits
- Easy, user-friendly trading
Is it a good time to buy Regeneron Pharmaceuticals stock?
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
Technical analysis
View Regeneron Pharmaceuticals's price performance, share price volatility, historical data and technicals.
Share price volatility
Over the last 12 months, Regeneron Pharmaceuticals's shares have ranged in value from as little as $684.8 up to $998.33. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Regeneron Pharmaceuticals's is 0.168. This would suggest that Regeneron Pharmaceuticals's shares are less volatile than average (for this exchange).
Historical closes compared with the last close of $982.29
1 week (2024-05-12) | |
---|---|
1 month (2024-04-18) | |
3 months (2024-02-19) | |
6 months (2023-11-19) | |
1 year (2023-05-18) | |
2 years (2022-05-18) | |
3 years (2021-05-19) | |
5 years (2019-05-19) |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Is Regeneron Pharmaceuticals under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Regeneron Pharmaceuticals P/E ratio, PEG ratio and EBITDA.
Regeneron Pharmaceuticals's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Regeneron Pharmaceuticals's stocks trade at around 29x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Regeneron Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4591. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Regeneron Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Regeneron Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $4.4 billion.
The EBITDA is a measure of Regeneron Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
Buy Regeneron Pharmaceuticals stock from these brokers
Compare brokers by available asset types, minimum deposit, stock trade fee and more. Select Go to site to sign up for an account or select More Info to read our comprehensive review.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Frequently asked questions
More guides on Finder
-
Direct indexing: What it is and how it works
Direct indexing investment strategy as an alternative to investing in index funds while taking advantage of tax-loss harvesting.
-
Best stocks for beginners with little money
These are the stocks to buy when you don’t have much to spend.
-
11 best trading platforms for beginners of May 2024
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
6 best ETF brokers of May 2024
Check out our picks of the best ETF brokers for beginners, options trading, micro-investing and more.
-
9 best robo-advisors of May 2024
Check out our picks of the best robo-advisors for new and experienced investors alike.
-
11 best brokerage accounts of May 2024
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
SoFi Invest® review 2024
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to invest $50K
There are many ways to invest and grow $50K depending on your financial situation, personal needs and goals.
-
How to buy stocks online
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.
Ask a Question